Plasma exchange and rituximab treatments in primary membranous nephropathy combined with crescentic glomerulonephritis: A case report

RATIONALE: Crescent formation is rare in primary membranous nephropathy (MN). Anti-phospholipase A2 receptor (PLA2R) antibodies are detectable in these patients. The mechanism and treatments are unknown. PATIENT CONCERNS: A 72-year-old female patient who presented with nephrotic syndrome, hematuria,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Hui, Cui, Zhao, Zhou, Xu-jie, Jin, Qi-zhuang, Yu, Xiao-juan, Wang, Su-xia, Wang, Yu, Zhou, Fu-de, Zhao, Ming-hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504248/
https://www.ncbi.nlm.nih.gov/pubmed/31045764
http://dx.doi.org/10.1097/MD.0000000000015303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504248/
https://www.ncbi.nlm.nih.gov/pubmed/31045764
http://dx.doi.org/10.1097/MD.0000000000015303

Ejemplares similares